Oral risdiplam (Evrysdi, Genentech) started in the first 6 weeks of life let most infants with presymptomatic spinal muscular atrophy (SMA) reach motor milestones typical of healthy babies, results of ...

The in-service evaluation of newborn screening for spinal muscular atrophy (SMA) launched across Scotland in March and is the ...

Emma Ciafaloni, MD, FAAN, explores the groundbreaking approval of onasemnogene abeparvovec-xioi for spinal muscular atrophy and its impact on the treatment paradigm for this rare disease. This is a ...

Spinal muscular atrophy (SMA) is a rare genetic condition that causes progressive muscle weakness, which, when untreated, prevents infants with the most severe form from gaining motor ...

Spinal muscular atrophy (SMA) is a severe neurological disease for which there is presently no cure, although current therapies can alleviate symptoms. In the search for better treatment options, ...

NOW PLAYING Biotech Stocks Are Shooting Higher. Here's How You Can Play Them. The company tested a drug called apitegromab in patients with the muscle-wasting disease. After a year, patients age 2 to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Jordanian girl Katia Abu Al-Saud arrives in Dubai for spinal muscular atrophy treatment sponsored by Sheikh Mohammed bin ...

With the intensification of global population aging, muscle atrophy, characterized by the loss of muscle mass and function, has become an important health issue affecting the elderly. Researchers have ...

Muscle atrophy is a prevalent condition in today's societies, but many of the roles that mitochondria play in the process remain unclear. In a recent study, researchers investigated how muscle atrophy ...

Sheikh Mohammed sponsors life-saving treatment for 11-year-old Abdul Rahman battling spinal muscular atrophy, offering hope ...